Trials / Terminated
TerminatedNCT00316433
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer
Phase II Study of Oxaliplatin and CPT-11 as First Line Treatment for Extensive Stage Small Cell Lung Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Swedish Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and effectiveness of the combination of oxaliplatin and irinotecan (CPT-11) in patients with previously untreated, advanced small cell lung cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Irinotecan (CPT-11) | |
| DRUG | Oxaliplatin (Eloxatin) |
Timeline
- Start date
- 2005-02-01
- Completion
- 2007-01-01
- First posted
- 2006-04-20
- Last updated
- 2007-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00316433. Inclusion in this directory is not an endorsement.